Fiber intake predicts ghrelin levels in overweight and obese postmenopausal women

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 65-72

  St Pierre, David H ^a,f   Rabasa Lhoret, Rémi ^a,b,c   Lavoie, Marie Ève ^a   Karelis, Anthony D ^d   Strychar, Irene ^a   Doucet, Eric ^e   Coderre, Lise ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GHRELIN; GLUCOSE; LIPID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ACYLATION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY FIBER; EATING HABIT; FAT INTAKE; FEMALE; FOOD INTAKE; GLUCOSE CLAMP TECHNIQUE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; MACRONUTRIENT; OBESITY; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; BLOOD; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; METABOLISM; MIDDLE AGED; NUTRITIONAL ASSESSMENT; PHYSIOLOGY; PREDICTION AND FORECASTING;

AGED; BLOOD GLUCOSE; DIETARY FIBER; FASTING; FEMALE; FOOD HABITS; GHRELIN; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; MIDDLE AGED; NUTRITION ASSESSMENT; OBESITY; OVERWEIGHT; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS;

EID: 67650712274     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0018     Document Type: Article

References (53)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
2. Wiedmer P, Nogueiras R, Broglio F, D'Alessio D & Tschop MH. Ghrelin, obesity and diabetes. Nature Clinical Practice. Endocrinology and Metabolism 2007 3 705-712.
3. Tschop M, Smiley DL & Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407 908-913.
4. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA & Bloom SR. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000 141 4325-4328.
5. De Vriese C & Delporte C. Influence of ghrelin on food intake and energy homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 615-619.
6. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K & Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 2002 87 240-244.
7. St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard JP, Cianflone K, Doucet E, Imbeault P & Rabasa-Lhoret R. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 264-269.
8. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP & Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 1623-1630.
9. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 3062-3065.
10. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E & van der Lely AJ. Ghrelin stimulates, whereas desoctanoyl ghrelin inhibits, glucose output by primary hepatocytes. Journal of Clinical Endocrinology and Metabolism 2005 90 1055-1060.
11. Gauna C, Delhanty PJ, van Aken MO, Janssen JA, Themmen AP, Hofland LJ, Culler M, Broglio F, Ghigo E & van der Lely AJ. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Molecular and Cellular Endocrinology 2006 251 103-111.
12. Gauna C, Kiewiet RM, Janssen JA, van de Zande B, Delhanty PJ, Ghigo E, Hofland LJ, Themmen AP & van der Lely AJ. Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E697-E704.
13. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, Hofland LJ, Broglio F, Ghigo E & van der Lely AJ. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5035-5042.
14. Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiology and Behaviour 2006 89 71-84.
15. Gerstein DE, Woodward-Lopez G, Evans AE, Kelsey K & Drewnowski A. Clarifying concepts about macronutrients' effects on satiation and satiety. Journal of the American Dietetic Association 2004 104 1151-1153.
16. Foster-Schubert KE, Overduin J, Prudom CE, Liu J, Callahan HS, Gaylinn BD, Thorner MO & Cummings DE. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. Journal of Clinical Endocrinology and Metabolism 2008 93 1971-1979.
17. Marzullo P, Caumo A, Savia G, Verti B, Walker GE, Maestrini S, Tagliaferri A, Di Blasio AM & Liuzzi A. Predictors of postabsorptive ghrelin secretion after intake of different macronutrients. Journal of Clinical Endocrinology and Metabolism 2006 91 4124-4130.
18. Gomez G, Englander EW & Greeley GH Jr. Nutrient inhibition of ghrelin secretion in the fasted rat. Regulatory Peptides 2004 117 33-36.
19. Erdmann J, Lippl F & Schusdziarra V. Differential effect of protein and fat on plasma ghrelin levels in man. Regulatory Peptides 2003 116 101-107.
20. Weickert MO & Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. Journal of Nutrition 2008 138 439-442.
21. Slavin JL. Dietary fiber and body weight. Nutrition 2005 21 411-418.
22. Venn BJ & Mann JI. Cereal grains, legumes and diabetes. European Journal of Clinical Nutrition 2004 58 1443-1461.
23. Lairon D. Macronutrient intake and modulation on chylomicron production and clearance. Atherosclerosis 2008 9 45-48.
24. Kan H, Stevens J, Heiss G, Klein R, Rose KM & London SJ. Dietary fiber intake and retinal vascular caliber in the Atherosclerosis Risk in Communities Study. American Journal of Clinical Nutrition 2007 86 1626-1632.
25. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R & Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5083-5086.
26. St-Pierre DH, Karelis AD, Cianflone K, Conus F, Mignault D, Rabasa-Lhoret R, St-Onge M, Tremblay-Lebeau A & Poehlman ET. Relationship between ghrelin and energy expenditure in healthy young women. Journal of Clinical Endocrinology and Metabolism 2004 89 5993-5997.
27. St-Pierre DH, Bastard JP, Coderre L, Brochu M, Karelis AD, Lavoie ME, Malita F, Fontaine J, Mignault D, Cianflone K, Imbeault P, Doucet E & Rabasa-Lhoret R. Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study. European Journal of Endocrinology 2007 157 419-426.
28. DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 E214-E223.
29. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
31. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA & Poehlman ET. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? Journal of Clinical Endocrinology and Metabolism 2001 86 1020-1025.
32. Bernier P & Laurent L. Evaluation nutritionelle. In Manuel de Nutrition Clinique. Ordre professionnel des dietetistes du Quebec, edn 3, Ch 1.2, p 4. Ed Guy Connolly. Montreal, Québec, Canada, 2000.
33. Murdolo G, Lucidi P, Di Loreto C, Parlanti N, De Cicco A, Fatone C, Fanelli CG, Bolli GB, Santeusanio F & De Feo P. Insulin is required for prandial ghrelin suppression in humans. Diabetes 2003 52 2923-2927.
34. Mohlig M, Spranger J, Otto B, Ristow M, Tschop M & Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. Journal of Endocrinological Investigation 2002 25 RC36-RC38.
35. Spranger J, Ristow M, Otto B, HeldweinW, Tschop M, Pfeiffer AF & Mohlig M. Post-prandial decrease of human plasma ghrelin in the absence of insulin. Journal of Endocrinological Investigation 2003 26 RC19-RC22.
36. Gruendel S, Garcia AL, Otto B, Mueller C, Steiniger J,Weickert MO, Speth M, Katz N & Koebnick C. Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. Journal of Nutrition 2006 136 1533-1538.
37. Lee YP, Mori TA, Sipsas S, Barden A, Puddey IB, Burke V, Hall RS & Hodgson JM. Lupin-enriched bread increases satiety and reduces energy intake acutely. American Journal of Clinical Nutrition 2006 84 975-980.
38. Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK & Herzig KH. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regulatory Peptides 2008 149 70-78.
39. Nedvidkova J, Krykorkova I, Bartak V, Papezova H, Gold PW, Alesci S & Pacak K. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2003 88 1678-1682.
40. Weickert MO, Spranger J, Holst JJ, Otto B, Koebnick C, Mohlig M & Pfeiffer AF. Wheat-fibre-induced changes of postprandial peptide YYand ghrelin responses are not associated with acute alterations of satiety. British Journal of Nutrition 2006 96 795-798.
41. Nilsson AC, Ostman EM, Holst JJ & Bjorck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. Journal of Nutrition 2008 138 732-739.
42. Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E & Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007 30 2804-2810.
43. Kaline K, Bornstein SR, Bergmann A, Hauner H & Schwarz PE. The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products. Hormone and Metabolic Research 2007 39 687-693.
44. Salas-Salvado J, Farres X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bullo M & Balanza R. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. British Journal of Nutrition 2008 99 1380-1387.
45. Samra RA & Anderson GH. Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men. American Journal of Clinical Nutrition 2007 86 972-979.
46. Ma Y, Hebert JR, LiW, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, Griffith JA & Liu S. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 2008 24 941-949.
47. Schmid DA, Held K, Ising M, Uhr M, Weikel JC & Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005 30 1187-1192.
48. Callahan HS, Cummings DE, Pepe MS, Breen PA, Matthys CC & Weigle DS. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 1319-1324.
49. le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA & Bloom SR. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. Journal of Clinical Endocrinology and Metabolism 2005 90 1068-1071.
50. Schneeman BO. Gastrointestinal physiology and functions. British Journal of Nutrition 2002 88 S159-S163.
51. Despres JP. Intra-abdominal obesity: an untreated risk factor for type 2 diabetes and cardiovascular disease. Journal of Endocrinological Investigation 2006 29 77-82.
52. Schweizer TF & Wursch P. The physiological and nutritional importance of dietary fibre. Experientia 1991 47 181-186.
53. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D & Rabasa-Lhoret R. The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism 2005 90 4145-4150.